ArticleSmall (Weinheim an der Bergstrasse, Germany)2026
Supramolecular Microcapsules via Microfluidic Interfacial Host-Guest Assembly: A Novel Strategy for Actives Encapsulation and Stimuli-Responsive Delivery.
Article in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The development of intelligent encapsulation systems that ensure both the stability and stimuli-responsive release of sensitive actives remains a critical challenge for personal care and pharmaceutical applications. This work presents a supramolecular strategy to fabricate intelligent microcapsules by integrating droplet microfluidics with host-guest chemistry. Specifically, phenylalanine-functionalized chitosan (CS-Phe) is designed to function as the guest polymer. Within the microfluidic system, positively charged CS-Phe is electrostatically anchored at the water-oil interface and dynamically crosslinked by cucurbit[8]uril (CB[8]), thereby forming monodisperse microcapsules with tunable sizes and shapes. These microcapsules exhibit high encapsulation stability and are dual-responsive to pH variations and competitive guests. This combination of properties establishes the resulting supramolecular microcapsules as a versatile platform for the intelligent encapsulation and on-demand release of active ingredients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.